Keywords: Parkinson's Disease, Quantitative Imaging, MEGA-PRESS
Motivation: Altered λ-aminobutyric acid (GABA) levels have been observed in Parkinson's disease (PD), and these discrepancies may depend in differences of clinical symptoms. However, the role o GABA and glutamate concentrations of depression in Parkinson's disease (DPD) remains unexplored.
Goal(s): To explore the changes of GABA+, glutamate and glutamate (Glx) in DPD.
Approach: We utilized MEGA-PRESS to measure GABA+ and Glx levels in the medial frontal cortex (MFC) and thalamus among PD patients with and without depression, along with aged-matched healthy participants.
Results: GABA+ levels were found to be elevated within MFC in individuals with DPD, independent of the presence of Parkinson’s disease.
Impact: These findings suggest that GABAergic alterations in specific brain regions might be linked to the clinical symptoms of PD. Modulating GABAergic function could be a potential approach for treating DPD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords